Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selnoflast in atherosclerosis
NCT07448038Phase 2Recruiting
- Sponsor
- Genentech
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of selnoflast in atherosclerosis, sponsored by Genentech. Started Jun 2026; status: recruiting.
02
Drugs
selnoflast
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT07448038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448038.